Literature DB >> 14249185

PROLIFERATIVE DIABETIC RETINOPATHY: EVOLUTION OF THE RETINAL LESIONS.

J H DOBREE.   

Abstract

Entities:  

Keywords:  CONNECTIVE TISSUE; DIABETIC RETINOPATHY; PATHOLOGY; RETINA; RETINAL HEMORRHAGE; RETINAL VESSELS

Mesh:

Year:  1964        PMID: 14249185      PMCID: PMC506037          DOI: 10.1136/bjo.48.12.637

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  13 in total

1.  TREATMENT OF DIABETIC RETINOPATHY BY LIGHT-COAGULATION: A PRELIMINARY STUDY.

Authors:  P C WETZIG; J T WORLTON
Journal:  Br J Ophthalmol       Date:  1963-09       Impact factor: 4.638

2.  Retinal vascular patterns. IV. Diabetic retinopathy.

Authors:  D G COGAN; D TOUSSAINT; T KUWABARA
Journal:  Arch Ophthalmol       Date:  1961-09

3.  Favourable effect of durabolin (19-nor-androstenolon-phenyl-propionate) on diabetic retinopathy.

Authors:  P BEAUMONT; J vd BOOGAARD
Journal:  Ophthalmologica       Date:  1960-06       Impact factor: 3.250

4.  Proliferative retinopathy in diabetes mellitus; review of eight hundred forty-seven cases.

Authors:  H F ROOT; S MIRSKY; J DITZEL
Journal:  J Am Med Assoc       Date:  1959-02-28

5.  Retinal neovascularization.

Authors:  G N WISE
Journal:  Trans Am Ophthalmol Soc       Date:  1956

6.  Retinopathia diabetica proliferans.

Authors:  T KORNERUP
Journal:  Acta Ophthalmol (Copenh)       Date:  1958

7.  [Diabetic retinopathy].

Authors:  J BABEL; B RILLIET
Journal:  Ophthalmologica       Date:  1958 May-Jun       Impact factor: 3.250

8.  [Not Available].

Authors:  R LUFT; H OLIVECRONA; D IKKOS; T KORNERUP; H LJUNGGREN; L B NILSSON; B SJOGREN
Journal:  Nord Med       Date:  1956-05-24

9.  Connective tissue changes in diabetic eyes.

Authors:  E LINNER; B TENGROTH
Journal:  Acta Ophthalmol (Copenh)       Date:  1962

10.  Ocular pathology of diabetes.

Authors:  S GARTNER
Journal:  Am J Ophthalmol       Date:  1950-05       Impact factor: 5.258

View more
  17 in total

1.  Photocoagulation for peripheral neovascularisation in diabetes.

Authors:  D V Inglesby; G S Turner; W E Schulenburg; E M Kohner
Journal:  Br J Ophthalmol       Date:  1985-03       Impact factor: 4.638

2.  Diabetic Retinopathy and the NMDA Receptor.

Authors:  Sylvia B. Smith
Journal:  Drug News Perspect       Date:  2002-05

3.  Ocular findings in 123 patients with proliferative diabetic retinopathy. 3. Changes in the posterior segment of the eye.

Authors:  P H Madsen
Journal:  Doc Ophthalmol       Date:  1971-05-14       Impact factor: 2.379

4.  Prognosis for vision and fundus changes in patients with proliferative diabetic retinopathy.

Authors:  P H Madsen
Journal:  Br J Ophthalmol       Date:  1971-06       Impact factor: 4.638

5.  Sequelae to preretinal haemorrhage in proliferative diabetic retinopathy.

Authors:  E Taylor
Journal:  Br J Ophthalmol       Date:  1969-09       Impact factor: 4.638

6.  Proliferative diabetic retinopathy. Regression of optic disc neovascularization after retinal photocoagulation.

Authors:  E Taylor
Journal:  Br J Ophthalmol       Date:  1970-08       Impact factor: 4.638

7.  Cutaneous capillary resistance and retinal haemorrhage in diabetes.

Authors:  P R Hunter; A Bloom; J H Kelsey; R Porter
Journal:  Diabetologia       Date:  1971-02       Impact factor: 10.122

8.  Diabetic retinopathy: fibrotic proliferation and retinal detachment.

Authors:  J W McMeel
Journal:  Trans Am Ophthalmol Soc       Date:  1971

9.  Comparison of the progress of flat new vessels on the optic disc with those on the retina in patients treated by pituitary ablation.

Authors:  R S Elkeles; R K Blach; G F Joplin
Journal:  Diabetologia       Date:  1971-04       Impact factor: 10.122

10.  Morphological differences between optic disc collaterals and neovascularization on optical coherence tomography angiography.

Authors:  Ankur Singh; Aniruddha Agarwal; Sarakshi Mahajan; Samendra Karkhur; Ramandeep Singh; Reema Bansal; Mangat R Dogra; Vishali Gupta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-09       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.